Company Filing History:
Years Active: 2002-2017
Title: Christian Engwerda: Innovator in Bromelain Research
Introduction
Christian Engwerda is a notable inventor based in Richmond, GB. He has made significant contributions to the field of biochemistry, particularly through his work on bromelain. With a total of 3 patents, Engwerda's innovations have the potential to impact medical treatments significantly.
Latest Patents
One of Engwerda's latest patents focuses on a component of bromelain that is crucial for interrupting the MAP kinase cascade. This component, which includes ananain and comosain, is useful in treating or preventing diseases and conditions mediated by T cell activation or by activation of the MAP kinase pathway. This invention highlights the therapeutic potential of bromelain in various medical applications.
Career Highlights
Throughout his career, Engwerda has worked with several companies, including Sarantis Pty Ltd and Provalis UK Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the field.
Collaborations
Engwerda has collaborated with professionals such as Tracey Lehanne Mynott and Keith Peek. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Christian Engwerda's work in the field of bromelain research exemplifies the impact of innovation on medical science. His patents and collaborations reflect a commitment to advancing healthcare solutions.